CSL Ltd ADR (Sponsored)


By |


CSL is a global biopharmaceutical company that manufactures and markets biotherapies, predominantly derived from immunoglobulins, in turn extracted from blood plasma. The latter is mostly sourced from collection centres in the United States and Germany. It is one of three major players in the global blood-plasma-derived biotherapies space and owns about one third of the lucrative U.S. immunoglobulin market. Products treat diseases and conditions such as haemophilia, immune deficiency, and inherited respiratory disease.

Contact Information

Website: www.csl.com.au
Email: Bernard.Ronchi@csl.com.au
Main Phone: +61 393891911
Address: 45 Poplar Road
State: VIC
City / Town: Parkville
Country: AUS
Postal Code: 3052

Issuer Information

Exchange: OTO
Employees: 10411
NAICS: Medicinal and Botanical Manufacturing(325411)
$ 64.74 $ -0.41 (-0.63%)
Last Price 64.74 Change $ -0.41 Change % -0.63 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 64.85 High 65.40 Low 64.56 Prev Close 65.15
Last Trade Volume 59,223 52 Wk Hi 83.12 52 Wk Low 53.26
Market Cap 58.6 bi Ex-Div Date Div Rate 0.81 Yield 1.2500
Shares 905,916,174.00 EPS (TTM) 1.91 PE Ratio 33.40 Exchange OTCPK